Measurement | Before (week 0) | Baseline (week 0) | Intervention (week 1-week 12) | End of intervention (week 12) | Follow-up (week 24) |
---|---|---|---|---|---|
Enrollment | |||||
 Recruitment and screening | X |  |  |  |  |
 Information consent | X |  |  |  |  |
 Allocation |  | X |  |  |  |
 LRE-BFR |  |  | X |  |  |
 CRE |  |  | X |  |  |
 CG |  |  | X |  |  |
Primary outcomes | |||||
 PBF |  | X |  | X | X |
 KES |  | X |  | X | X |
Secondary outcomes | |||||
 Body composition |  | X |  | X | X |
 Anthropometric measurements |  | X |  | X | X |
 Muscle strength of upper limbs |  | X |  | X | X |
 Physical performance |  | X |  | X | X |
 Hematological parameters and CVD risk factors |  | X |  | X | X |
 Quality of life |  | X |  | X | X |
Others | |||||
 Participants' compliance |  |  | X | X | X |
 Adverse events |  |  | X | X | X |
 Reasons for dropout |  |  | X | X | X |